Pharmacotherapy of Attention-Deficit/ Hyperactivity Disorder in Individuals with Autism Spectrum Disorder

被引：8
作者：
Joshi, Gagan [1 ,2 ,3 ]
Wilens, Timothy E. [2 ,3 ]
机构：
[1] Massachusetts Gen Hosp, Alan & Lorraine Bressler Clin & Res Program Autis, 55 Fruit St,WRN 626, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Clin & Res Program Pediat Psychopharmacol, Boston, MA 02114 USA
[3] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA
来源：
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA | 2022年 / 31卷 / 03期
关键词：
ADHD; ASD; Comorbidity; Treatment; PERVASIVE DEVELOPMENTAL DISORDERS; DEFICIT/HYPERACTIVITY DISORDER; PSYCHIATRIC COMORBIDITY; CHILDREN; METHYLPHENIDATE; ATOMOXETINE; EFFICACY; ADOLESCENTS; CROSSOVER; SYMPTOMS;
D O I：
10.1016/j.chc.2022.03.012
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页码：449 / 468
页数：20
相关论文
共 26 条
  • [1] Aman MG, 2005, ARCH GEN PSYCHIAT, V62, P1266
  • [2] American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596.744053]
  • [3] Atomoxetine for hyperactivity in autism spectrum disorders: Placebo-controlled crossover pilot trial
    Arnold, L. Eugene
    Aman, Michael G.
    Cook, Amelia M.
    Witwer, Andrea N.
    Hall, Kristy L.
    Thompson, Susan
    Ramadan, Yaser
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (10) : 1196 - 1205
  • [4] Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study
    Biederman, Joseph
    Monuteaux, Michael C.
    Spencer, Thomas
    Wilens, Timothy E.
    Faraone, Stephen V.
    [J]. PEDIATRICS, 2009, 124 (01) : 71 - 78
  • [5] Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis
    Cheng, Jackie Y. W.
    Chen, Ronald Y. L.
    Ko, John S. N.
    Ng, Emil M. L.
    [J]. PSYCHOPHARMACOLOGY, 2007, 194 (02) : 197 - 209
  • [6] Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
    Faraone, Stephen V.
    Buitelaar, Jan
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2010, 19 (04) : 353 - 364
  • [7] Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental Disorders
    Ghuman, Jaswinder K.
    Aman, Michael G.
    Lecavalier, Luc
    Riddle, Mark A.
    Gelenberg, Alan
    Wright, Ron
    Rice, Sydney
    Ghuman, Harinder S.
    Fort, Carolyn
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (04) : 329 - 339
  • [8] Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder
    Handen, Benjamin L.
    Aman, Michael G.
    Arnold, L. Eugene
    Hyman, Susan L.
    Tumuluru, Rameshwari V.
    Lecavalier, Luc
    Corbett-Dick, Patricia
    Pan, Xueliang
    Hollway, Jill A.
    Buchan-Page, Kristin A.
    Silverman, Laura B.
    Brown, Nicole V.
    Rice, Robert R., Jr.
    Hellings, Jessica
    Mruzek, Daniel W.
    McAuliffe-Bellin, Sarah
    Hurt, Elizabeth A.
    Ryan, Melissa M.
    Levato, Lynne
    Smith, Tristram
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2015, 54 (11) : 905 - 915
  • [9] Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder
    Handen, BL
    Johnson, CR
    Lubetsky, M
    [J]. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2000, 30 (03) : 245 - 255
  • [10] Atomoxetine in Autism Spectrum Disorder: No Effects on Social Functioning; Some Beneficial Effects on Stereotyped Behaviors, Inappropriate Speech, and Fear of Change
    Harfterkamp, Myriam
    Buitelaar, Jan K.
    Minderaa, Ruud B.
    van de Loo-Neus, Gigi
    van der Gaag, Rutger-Jan
    Hoekstra, Pieter J.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (09) : 481 - 485
123